• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A low-dose immune tolerance induction (ITI) protocol incorporating immunosuppressive agents in haemophilia A children with high-titre factor VIII inhibitor and poor-ITI prognostic risk.

作者信息

Li Zekun, Chen Zhenping, Cheng Xiaoling, Liu Guoqing, Wu Xinyi, Li Gang, Zhen Yingzi, Cai Siyu, Poon Man-Chiu, Wu Runhui

机构信息

Haemophilia Work Group, National Center for Children's Health, Beijing Children's Hospital affiliated to Capital Medical University, Beijing, China.

Epidemiology department, National Center for Children's Health, Beijing Children's Hospital affiliated to Capital Medical University, Beijing, China.

出版信息

Haemophilia. 2021 Jul;27(4):e469-e472. doi: 10.1111/hae.14157. Epub 2020 Nov 20.

DOI:10.1111/hae.14157
PMID:33216409
Abstract
摘要

相似文献

1
A low-dose immune tolerance induction (ITI) protocol incorporating immunosuppressive agents in haemophilia A children with high-titre factor VIII inhibitor and poor-ITI prognostic risk.一种低剂量免疫耐受诱导（ITI）方案，该方案在患有高滴度因子VIII抑制剂且ITI预后风险较差的甲型血友病儿童中加入了免疫抑制剂。
Haemophilia. 2021 Jul;27(4):e469-e472. doi: 10.1111/hae.14157. Epub 2020 Nov 20.
2
First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.在一项观察性免疫耐受诱导研究中，关于高危血友病A抑制物患者使用单一凝血因子VIII/血管性血友病因子浓缩物的免疫耐受的首份前瞻性报告。
Haemophilia. 2016 Jan;22(1):87-95. doi: 10.1111/hae.12774. Epub 2015 Jul 23.
3
Low-dose immune tolerance induction therapy in children of Arab descent with severe haemophilia A, high inhibitor titres and poor prognostic factors for immune tolerance induction treatment success.在具有高抑制剂滴度和免疫耐受诱导治疗成功不良预后因素的阿拉伯裔重度血友病 A 儿童中进行低剂量免疫耐受诱导治疗。
Haemophilia. 2022 Jan;28(1):65-72. doi: 10.1111/hae.14456. Epub 2021 Nov 19.
4
Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units.成功诱导低剂量免疫耐受治疗严重血友病 A 伴低于 40 贝塞斯达单位抑制剂
Haemophilia. 2010 May;16(102):71-9. doi: 10.1111/j.1365-2516.2010.02225.x.
5
Eradication of FIX inhibitor in haemophilia B children using low-dose immune tolerance induction with rituximab-based immunosuppressive agent(s) in China.在中国，采用基于利妥昔单抗的免疫抑制剂进行低剂量免疫耐受诱导以根除B型血友病患儿体内FIX抑制剂。
Haemophilia. 2022 Jul;28(4):625-632. doi: 10.1111/hae.14577. Epub 2022 May 3.
6
Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors.诱导免疫耐受治疗伴有凝血因子 VIII 抑制物的儿童甲型血友病患者
Haemophilia. 2000 May;6(3):150-7. doi: 10.1046/j.1365-2516.2000.00379.x.
7
Immune tolerance induction with moroctocog-alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high-titre inhibitors: Data from REF.IT Registry.免疫耐受诱导与莫罗考帕-α（瑞福/瑞福 AF）在意大利高滴度抑制剂血友病 A 患者人群：REF.IT 登记处的数据。
Haemophilia. 2019 Nov;25(6):1003-1010. doi: 10.1111/hae.13859. Epub 2019 Oct 11.
8
Immune tolerance induction using a factor VIII/von Willebrand factor concentrate (BIOSTATE), with or without immunosuppression, in Australian paediatric severe haemophilia A patients with high titre inhibitors: a multicentre, retrospective study.在澳大利亚患有高滴度抑制物的儿童重度甲型血友病患者中，使用含或不含免疫抑制的凝血因子 VIII/血管性血友病因子浓缩物（BIOSTATE）诱导免疫耐受：一项多中心回顾性研究。
Thromb Res. 2014 Nov;134(5):1046-51. doi: 10.1016/j.thromres.2014.09.010. Epub 2014 Sep 21.
9
Immune tolerance induction rescue with turoctocog-alfa in a poor risk haemophilia A inhibitor young child: the history of a success.用重组人凝血因子VIII（turoctocog-alfa）诱导免疫耐受挽救一名高危血友病A抑制物患儿：成功案例
Blood Coagul Fibrinolysis. 2018 Jul;29(5):465-468. doi: 10.1097/MBC.0000000000000736.
10
Inhibitors in haemophilia A: current management and open issues.甲型血友病的抑制剂：当前的管理及未解决的问题
Haemophilia. 2007 Dec;13 Suppl 5:52-60. doi: 10.1111/j.1365-2516.2007.01574.x.

引用本文的文献

1
[Chinese guidelines on the diagnosis and management of hemophilia with inhibitors (2023)].[中国血友病合并抑制物诊断与治疗指南（2023年版）]
Zhonghua Xue Ye Xue Za Zhi. 2023 Nov 14;44(11):881-889. doi: 10.3760/cma.j.issn.0253-2727.2023.11.001.
2
Low-dose immune tolerance induction in children with severe hemophilia A with high-titer inhibitors: Type of factor 8 mutation and outcomes.高滴度抑制物的重度甲型血友病儿童低剂量免疫耐受诱导：凝血因子8突变类型及结果
Res Pract Thromb Haemost. 2022 Oct 26;6(7):e12824. doi: 10.1002/rth2.12824. eCollection 2022 Oct.